Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model. Journal of Applied Oral Science, [S. l.], v. 27, p. e20180211, 2019. DOI: 10.1590/1678-7757-2018-0211. Disponível em: https://www.revistas.usp.br/jaos/article/view/158652.. Acesso em: 2 may. 2024.